89955-40-8 Usage
Uses
Used in Pharmaceutical Synthesis:
Benzoic acid, 3-((4-(3-cyclohexyl-3-hydroxy-1-propenyl)hexahydro-5-hydroxy-2(1H)-pentalenylidene)methyl)-, (2E,3alpha,4alpha(1E,3R),5beta, 6aalpha)-(+-)is used as a key intermediate in the synthesis of pharmaceutical compounds due to its complex and specific structure. Its unique properties and reactivity may contribute to the development of novel drugs with improved therapeutic effects.
Used in Medicinal Chemistry Research:
Benzoic acid, 3-((4-(3-cyclohexyl-3-hydroxy-1-propenyl)hexahydro-5-hyd roxy-2(1H)-pentalenylidene)methyl)-, (2E,3aalpha,4alpha(1E,3R),5beta, 6aalpha)-(+-)is utilized in medicinal chemistry research to explore its potential as a bioactive molecule. Its complex structure and specific stereochemistry may offer insights into the design and optimization of new therapeutic agents, particularly in the areas of drug discovery and development.
Used in Chemical Research and Development:
Benzoic acid, 3-((4-(3-cyclohexyl-3-hydroxy-1-propenyl)hexahydro-5-hydroxy-2(1H)-pentalenylidene)methyl)-, (2E,3alpha,4alpha(1E,3R),5beta, 6aalpha)-(+-)is employed in chemical research and development to study its unique properties and reactivity. Understanding its behavior in various chemical reactions can contribute to the advancement of synthetic chemistry and the discovery of new chemical processes.
Check Digit Verification of cas no
The CAS Registry Mumber 89955-40-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,9,9,5 and 5 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 89955-40:
(7*8)+(6*9)+(5*9)+(4*5)+(3*5)+(2*4)+(1*0)=198
198 % 10 = 8
So 89955-40-8 is a valid CAS Registry Number.
InChI:InChI=1/C25H32O4/c26-23(18-6-2-1-3-7-18)10-9-21-22-14-17(13-20(22)15-24(21)27)11-16-5-4-8-19(12-16)25(28)29/h4-5,8-12,18,20-24,26-27H,1-3,6-7,13-15H2,(H,28,29)/b10-9+,17-11+/t20-,21+,22-,23+,24+/m1/s1
89955-40-8Relevant academic research and scientific papers
Designing prostacyclin analogues
Flohe,Bohlke,Frankus,Kim,Lintz,Loschen,Michel,Mueller,Schneider,Seipp
, p. 1240 - 1248 (2007/10/02)
A series of prostacyclin analogues were synthesized and investigated for influence on blood pressure in rats, in vivo inhibition of platelet aggregation in rats, and in vitro inhibition of platelet aggregation in human platelet-rich plasma. The common fea
